Indianapolis-based Lilly is touting the world’s first clinical trial for an antibody treatment to fight COVID-19.
00:27 #AstraZeneca Full-Throttle with the Oxford Vaccine Including $1B from BARDA Despite Some Concerning Chatter: AstraZeneca has received over $1 billion from the United States government, via BARDA investment, to support development and production of the Oxford University vaccine it…
The World Health Organization has temporarily halted trials on hydroxychloroquine due to safety concerns. According to a study by The Lancet, patients given HCQ had higher death rates than those not on the drug. WHO will review the data collected…
Hindustan Times’ National Political Editor, Sunetra Choudhury brings you the top stories you need to know. Sunetra talks about the number of covid-19 cases in India, deaths in the country due to the virus, WHO’s decision to suspend trial of…
Australia’s first human trials of a potential COVID-19 vaccine started in Melbourne today, with about 130 people involved in the program. Clinical research organisation the Nucleus Network will be in charge of the early stages of testing the vaccine NVX-CoV2373,…
Monkeys given six prototype coronavirus vaccines were protected from infection in Harvard study that offers hope a jab to protect humans could be on the horizon Trials showed promising signs on a coronavirus vaccine after monkeys showed immunity after being…
